As of Jul 31
| +0.18 / +1.40%|
The 5 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 22.00, with a high estimate of 40.00 and a low estimate of 18.00. The median estimate represents a +69.23% increase from the last price of 13.00.
The current consensus among 5 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.